Holen Sie sich die Stockscreener-App
6.25
3.40%
-0.22
Handel nachbörslich:
6.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Oral Mucositis Market reached US$ 1.62 billion in 2023 and - openPR.com
Bausch + Lomb Brief: Adds Cause "Could Not Immediately Be Explained" - MarketScreener
Bausch + Lomb Brief: Announcing a Voluntary Recall of Intraocular Lenses (IOLs) On Its enVista Platform - MarketScreener
Bausch Health to Announce First Quarter Results on April 30 - guardonline.com
Bausch Health revenue by segment 2021-2024 - Statista
Bausch Health Upsizes Private Offering to $4.4 Billion - TipRanks
Bausch Health upsizes senior notes offering to $4.4 billion By Investing.com - Investing.com South Africa
Bausch Health upsizes senior notes offering to $4.4 billion - Investing.com India
Bausch Health Prices Upsized Private Offering of Senior Secured Notes - MarketScreener
Bausch Health Announces Pricing Of Upsized Private Offering Of Senior Secured Notes - Marketscreener.com
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes - ACCESS Newswire
Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago - Yahoo Finance
Bausch Health announces debt refinancing plans By Investing.com - Investing.com South Africa
Bausch Health announces debt refinancing plans - Investing.com
Bausch Health Announces Conditional Redemption of Senior Notes - TipRanks
Bausch Health Brief: Announcing Conditional Redemption of Senior Notes -March 21, 2025 at 04:24 pm EDT - MarketScreener
Bausch Health's Massive $7.4B Debt Overhaul Extends Maturity to 2032 - StockTitan
After losing 25% in the past year, Bausch Health Companies Inc. (NYSE:BHC) institutional owners must be relieved by the recent gain - simplywall.st
Bausch Health finance plan gets thumbs up at Raymond James - Cantech Letter
BHC Stock Price, News and Analysis - Cantech Letter
Optical Coherence Tomography Devices Market Future Business - openPR
Raymond James maintains Bausch Health stock Market Perform By Investing.com - Investing.com South Africa
Raymond James maintains Bausch Health stock Market Perform - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities - Investing.com Australia
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities By Investing.com - Investing.com South Africa
Bausch Health Launches $4 Billion Note Offering to Restructure Debt - TipRanks
Bausch Health Launches Syndication Of New Senior Secured Credit Facilities Totaling At Least $3.8 Bln - MarketScreener
Bausch Health Launches $3.8 Billion Credit Facilities -March 19, 2025 at 12:15 pm EDT - Marketscreener.com
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities - ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes - ACCESS Newswire
Intraocular Lens Market Research Methodologies Offers High - openPR
Bausch Health announces next steps in financining initiative - Yahoo Finance
Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com
Bausch Health seeks financing with J.P. Morgan aid By Investing.com - Investing.com South Africa
Bausch Health seeks financing with J.P. Morgan aid - Investing.com India
Bausch Health Brief: Says Has engaged J.P. Morgan in connection with Its previously announced financing objectives - Marketscreener.com
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan - Voice Of Alexandria
Bausch Health Taps JP Morgan to Lead Major Financial Restructuring Initiative - StockTitan
What is Zacks Research’s Forecast for BHC Q2 Earnings? - Defense World
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart
Microkeratome Market Detailed In New Research Report 2025 | - openPR
Overt Hepatic Encephalopathy Treatment Market: Key - openPR
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World
Cosmetic Surgery Market Forecast Report and Company - GlobeNewswire
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
1.48%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):